Expert Interviews

In part 2 of our interview, Lee Rosebush offers pharmacist-centered guidance on regulation and compliance amid COVID-19 vaccinations.

Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.

Kaitlyn Rivard, PharmD, infectious diseases clinical pharmacist at the Cleveland Clinic, spoke to Drug Topics about her role in getting their COVID-19 vaccination clinics off the ground.

Drug Topics interviewed Karen Mackinnon and Sara Revolinski from the Medical College of Wisconsin School of Pharmacy about how their pharmacy students have been rising to meet the demand of the pandemic by administering COVID-19 vaccines.

Drug Topics interviews Naomi Lopez, director of healthcare policy at the Goldwater Institute, focusing on expanding scope of practice and COVID-19 vaccine candidates already being used in other countries.

Perry Cohen, Drug Topics Editorial Advisory Board member, discusses key trends in hospital and community pharmacy settings.

Eric Levin, CEO of Scripta Insights, discusses trends that are shifting pharmacy toward delivery services and the impacts on the prescription drug market.

Stephen Schondelmeyer, PharmD, Drug Topics editorial advisory board member, discusses pharmacy highlights from 2020, and where he sees pharmacy headed in 2021.

Ken Thai, PharmD, Drug Topics editorial advisory board member, lists the key trends from 2020 and where he envisions pharmacy going in 2021.

Cody Clifton, PharmD, CPESN USA, discusses the organization's pharmacy integration network and the pharmacists' role amid the coronavirus pandemic.

Tim Suther, senior vice president of data solutions at Change Healthcare, discusses a new Social Determinants of Health Analytics resource.

Marie E. McDonnell, MD, discusses the latest on managing diabetes including treatment plans, therapies, technology, and more.

Robert Hopkins, chair of the National Vaccine Advisory Committee, discusses the most pressing issues coming out of the recent NVAC meeting and pharmacy's role amid the COVID-19 pandemic.

Robert Hopkins, chair of the National Vaccine Advisory Committee, discusses the most pressing issues coming out of the recent NVAC meeting, and pharmacy's role amid the COVID-19 pandemic.

Tim Jones, director of Managed Care, Elevate Provider Network, dives into the ways that pharmacists can engage with their customers - online and in their store - amid the COVID-19 pandemic during Medicare Part D open enrollment.

Brian Nightengale, President of GNP, discusses the value of Good Neighbor Pharmacy’s services and solutions in supporting independent community pharmacies now and in the future.

Beth Mitchell, Senior Director, Government Affairs, AmerisourceBergen, explains how independent community pharmacists can effectively advocate on behalf of their pharmacy on the federal and state levels.

Anna Dover, PharmD, discusses how modernizations in medication decision support are advancing pharmacy practice.

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.

Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring (CGM) technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.

In part 2 of our interview, Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

Kathleen Jaeger, NACDS senior vice president of pharmacy care and patient advocacy, offers key insights on a recent NY law that allows pharmacists to administer a COVID-19 vaccine once it becomes available.

In part 2 of our interview, Dr. Cheryl Wisseh, PharmD, MPH, zone 5 director, NPhA, dives into the forces that bring about racial disparities, and offers pharmacy and health system-centered solutions.

Dr. Cheryl Wisseh, PharmD, zone 5 director of the National Pharmaceutical Association (NPhA) discusses the ways that the current pandemic is displaying and doubling down on long standing disparities in our health care system.

Drug Topics interviews Steve Mok, PharmD, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence can mitigate challenges posed by the COVID-19 pandemic.

Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.